Karthick Mayilsamy

422 total citations
14 papers, 307 citations indexed

About

Karthick Mayilsamy is a scholar working on Neurology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Karthick Mayilsamy has authored 14 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Karthick Mayilsamy's work include SARS-CoV-2 and COVID-19 Research (3 papers), Mesenchymal stem cell research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Karthick Mayilsamy is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Mesenchymal stem cell research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Karthick Mayilsamy collaborates with scholars based in United States and India. Karthick Mayilsamy's co-authors include Subhra Mohapatra, Shyam S. Mohapatra, Mahasweta Das, Eleni Markoutsa, Bala Chandran, Xiaolan Tang, Jung Yeon Han, Alison E. Willing, Arunava Roy and Radouil Tzekov and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Molecular Therapy.

In The Last Decade

Karthick Mayilsamy

14 papers receiving 304 citations

Peers

Countries citing papers authored by Karthick Mayilsamy

Since Specialization

Citations

This map shows the geographic impact of Karthick Mayilsamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karthick Mayilsamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karthick Mayilsamy more than expected).

Fields of papers citing papers by Karthick Mayilsamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karthick Mayilsamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karthick Mayilsamy. The network helps show where Karthick Mayilsamy may publish in the future.

Co-authorship network of co-authors of Karthick Mayilsamy

This figure shows the co-authorship network connecting the top 25 collaborators of Karthick Mayilsamy. A scholar is included among the top collaborators of Karthick Mayilsamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karthick Mayilsamy. Karthick Mayilsamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis 2024 ·Viruses ·(unknown), Karthick Mayilsamy, Shyam S. Mohapatra, Subhra Mohapatra, (unknown), (unknown)	2
2	Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection 2023 ·Viruses ·(unknown), Eleni Markoutsa, Karthick Mayilsamy, Ryan Green, (unknown), Subhra Mohapatra, Shyam S. Mohapatra	6
3	A mouse model of repeated traumatic brain injury-induced hearing impairment: Early cochlear neurodegeneration in the absence of hair cell loss 2023 ·Hearing Research ·Courtney A. Penn, Karthick Mayilsamy, X. X. Zhu, (unknown), Shyam S. Mohapatra, Robert D. Frisina, Subhra Mohapatra	1
4	Targeting an evolutionarily conserved “E-L-L” motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2 2022 ·PNAS Nexus ·(unknown), (unknown), Karthick Mayilsamy, (unknown), (unknown), Sayan Das, (unknown), (unknown), (unknown), (unknown), Amit Kumar Das, Amit Basak, Shyam S. Mohapatra, Bala Chandran, (unknown), Subhra Mohapatra, Arunava Roy, Arindam Mondal	13
5	Ultrafast-UV laser integrating cavity device for inactivation of SARS-CoV-2 and other viruses 2022 ·Scientific Reports ·(unknown), Mark Howell, Karthick Mayilsamy, (unknown), Ryan Green, Subhra Mohapatra, Dmitri V. Voronine, Shyam S. Mohapatra	5
6	SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Karthick Mayilsamy, (unknown), (unknown), Bala Chandran, Laura J. Blair, Paula C. Bickford, Shyam S. Mohapatra, Subhra Mohapatra	22
7	Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced Infectivity 2022 ·Viruses ·(unknown), Karthick Mayilsamy, (unknown), (unknown), Marc A. Giulianotti, (unknown), Shyam S. Mohapatra, Subhra Mohapatra, Bala Chandran, Robert J. Deschenes, Arunava Roy	32
8	Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model 2021 ·Frontiers in Immunology ·Rinku Dutta, (unknown), Karthick Mayilsamy, Ryan Green, Mark Howell, (unknown), Shyam S. Mohapatra, Subhra Mohapatra, (unknown), (unknown)	15
9	Extracellular vesicles derived from inflammatory-educated stem cells reverse brain inflammation—implication of miRNAs 2021 ·Molecular Therapy ·Eleni Markoutsa, Karthick Mayilsamy, (unknown), Shyam S. Mohapatra, Subhra Mohapatra	34
10	Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury 2020 ·Nanomedicine Nanotechnology Biology and Medicine ·Karthick Mayilsamy, Eleni Markoutsa, Mahasweta Das, (unknown), (unknown), (unknown), Danielle Gulick, Alison E. Willing, Shyam S. Mohapatra, Subhra Mohapatra, (unknown), (unknown)	22
11	COVID-19 neurotropism and implications for therapy 2020 ·Neuroimmunology and Neuroinflammation ·Mahasweta Das, (unknown), (unknown), Karthick Mayilsamy, (unknown), (unknown), Shyam S. Mohapatra, Subhra Mohapatra	6
12	Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats 2019 ·Scientific Reports ·Mahasweta Das, Karthick Mayilsamy, Xiaolan Tang, Jung Yeon Han, (unknown), Alison E. Willing, Shyam S. Mohapatra, Subhra Mohapatra	25
13	CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies 2019 ·Journal of Neuroinflammation ·Mahasweta Das, Xiaolan Tang, Jung Yeon Han, Karthick Mayilsamy, (unknown), Manas R. Biswal, Radouil Tzekov, Shyam S. Mohapatra, Subhra Mohapatra	30
14	Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects 2019 ·Reviews in the Neurosciences ·Mahasweta Das, Karthick Mayilsamy, Shyam S. Mohapatra, Subhra Mohapatra	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact